Abstract:Cell replacement therapy is a promising treatment for irreversible retinal cell death in diverse diseases, such as age-related macular degeneration (AMD), Stargardt's disease, retinitis pigmentosa (RP) and glaucoma. These diseases are all characterized by the degeneration of one or two retinal cell types that cannot regenerate spontaneously in humans. Aberrant retinal pigment epithelial (RPE) cells can be observed through optical coherence tomography (OCT) in AMD patients. In RP patients, the morphological and functional abnormalities of RPE and photoreceptor layers are caused by a genetic abnormality. Stargardt's disease or juvenile macular degeneration, which is characterized by the loss of the RPE and photoreceptors in the macular area, causes central vision loss at an early age. Loss of retinal ganglion cells (RGCs) can be observed in patients with glaucoma. Once the retinal cell degeneration is triggered, no treatments can reverse it. Transplantation-based approaches have been proposed as a universal therapy to target patients with various concomitant diseases. Both the replacement of dead cells and neuroprotection are strategies used to rescue visual function in animal models of retinal degeneration. Diverse retinal cell types derived from pluripotent stem cells, including RPE cells, photoreceptors, RGCs and even retinal organoids with a layered structure, provide unlimited cell sources for transplantation. In addition, mesenchymal stem cells (MSCs) are multifunctional and protect degenerating retinal cells. The aim of this review is to summarize current findings from preclinical and clinical studies. We begin with a brief introduction to retinal degenerative diseases and cell death in diverse diseases, followed by methods for retinal cell generation. Preclinical and clinical studies are discussed, and future concerns about efficacy, safety and immunorejection are also addressed.

Research Progress of Stem Cell-Derived RPE Cell Transplantation Therapy for Retinal Degenerative Diseases

Advances of Stem Cell Transplantation in the Treatment of Retinal Degeneration

Progress of stem/progenitor cell-based therapy for retinal degeneration

Stem cell therapies for age-related macular degeneration: the past, present, and future.

Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration

Stem/progenitor Cell-Based Transplantation for Retinal Degeneration: a Review of Clinical Trials.

Stemming retinal regeneration with pluripotent stem cells

Stem/progenitor cells and biodegradable scaffolds in the treatment of retinal degenerative diseases.

Stem cells-based therapies for dry type of age related macular degeneration:current status and future prospects

Progress in stem cell transplantation for treatment of retinal ganglion cell damage diseases

Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases

Stem cell-derived retinal pigment epithelium cell therapy: Past and future directions

Development of stem cell-derived RPE for retinal degenerative diseases

Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects

Progress in Photoreceptor Replacement Therapy for Retinal Degenerative Diseases

Exploring Stem-Cell-Based Therapies for Retinal Regeneration

Progress of stem cells applications in retina repair

Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration

Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects

Mesenchymal Stem Cell Transplantation for Retinal Degenerations and Dystrophies: Present and Future

Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease